A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing Syndrome Interventions: Drug: ATR-101; Drug: Placebos Sponsor: Millendo Therapeutics, Inc. Not yet recruiting - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2017 Category: Research Source Type: clinical trials
A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing Syndrome Interventions: Drug: ATR-101; Drug: Placebos Sponsor: Millendo Therapeutics, Inc. Recruiting - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2017 Category: Research Source Type: clinical trials